Mirum Pharmaceuticals, Inc.
(MIRM - NASDAQ)
91,57 USD
📋 Profilo Aziendale

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases.

|